Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-30 @ 6:10 PM
Study NCT ID:
NCT05528861
Status:
TERMINATED
Last Update Posted:
2024-09-27
First Post:
2022-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria
Sponsor:
Allakos Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-01
First Submit QC Date:
None
Study First Post Date:
2022-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-03
Results First Submit QC Date:
None
Results First Post Date:
2024-09-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2024-09-27
Last Update Post Date Type:
ACTUAL